CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $21.43 ($123,459)
- 4 Open-market sale Chief Scientific Officer sold 3,408 shares at $20.67 ($70,436)
- 4 Open-market sale Chief Legal Officer sold 2,920 shares at $20.67 ($60,350)
- 4 Open-market sale Chief Financial Officer sold 2,490 shares at $20.67 ($51,463)
- 4 Gift Director gave 54,027 shares (gift)
- 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $20.81 ($119,837)
- 4 Planned sale Chief Financial Officer sold 20,000 shares at $20.01 ($400,216)
- 4 Planned sale Chief Legal Officer sold 1,864 shares at $17.02 ($31,721)
- 4 Planned sale Chief Legal Officer sold 1,900 shares at $17.01 ($32,319)
- 4 Planned sale Chief Legal Officer sold 400 shares at $17.00 ($6,801)
- 4 Planned sale Chief Legal Officer sold 1,596 shares at $17.01 ($27,153)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 3,499 shares at $12.83 ($44,878)
- 4 Open-market sale Chief Financial Officer sold 1,387 shares at $12.04 ($16,703)
- 4 Open-market sale Chief Scientific Officer sold 2,007 shares at $12.04 ($24,169)
Page 6 of 14 · 274 filings